Juan A. Jimenez-Marin

Barcelona, CT, Spain

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications

Sphingosine-1-Phosphate Receptor 1 Promotes Ovarian Cancer Tumorsphere Proliferation and Metastasis.

Sphingosine-1-Phosphate Receptor 1 Promotes Ovarian Cancer Tumorsphere Proliferation and Metastasis.

Journal: International journal of cancer
Published: July 28, 2025

Long-term outcomes of PARP inhibitors in ovarian cancer: survival, adverse events, and post-progression insights.

Long-term outcomes of PARP inhibitors in ovarian cancer: survival, adverse events, and post-progression insights.

Journal: ESMO open
Published: July 12, 2024

Myeloid cell networks govern re-establishment of original immune landscapes in recurrent ovarian cancer.

Myeloid cell networks govern re-establishment of original immune landscapes in recurrent ovarian cancer.

Journal: Cancer cell
Published: May 07, 2024

Study of late toxicity biomarkers of locally advanced head and neck cancer patients treated with radiotherapy plus cisplatin or cetuximab points to the relevance of skin macrophages (TOX-TTCC-2015-01).

Study of late toxicity biomarkers of locally advanced head and neck cancer patients treated with radiotherapy plus cisplatin or cetuximab points to the relevance of skin macrophages (TOX-TTCC-2015-01).

Journal: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico
Published: February 12, 2024

Ovarian cancer relies on the PDGFRβ-fibronectin axis for tumorsphere formation and metastatic spread.

Ovarian cancer relies on the PDGFRβ-fibronectin axis for tumorsphere formation and metastatic spread.

Journal: Molecular oncology
Published: August 17, 2023

Testing Cancer Immunotherapeutics in a Humanized Mouse Model Bearing Human Tumors.

Testing Cancer Immunotherapeutics in a Humanized Mouse Model Bearing Human Tumors.

Journal: Journal of visualized experiments : JoVE
Published: January 02, 2023

Paclitaxel Plus Cetuximab as Induction Chemotherapy for Patients With Locoregionally Advanced Head and Neck Squamous Cell Carcinoma Unfit for Cisplatin-Based Chemotherapy.

Paclitaxel Plus Cetuximab as Induction Chemotherapy for Patients With Locoregionally Advanced Head and Neck Squamous Cell Carcinoma Unfit for Cisplatin-Based Chemotherapy.

Journal: Frontiers in oncology
Published: May 25, 2022

Cabozantinib sensitizes microsatellite stable colorectal cancer to immune checkpoint blockade by immune modulation in human immune system mouse models.

Cabozantinib sensitizes microsatellite stable colorectal cancer to immune checkpoint blockade by immune modulation in human immune system mouse models.

Journal: Frontiers in oncology
Published: February 17, 2022

Facts and Hopes in Immunotherapy of Endometrial Cancer.

Facts and Hopes in Immunotherapy of Endometrial Cancer.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: January 17, 2022

Determinants and Functions of CAFs Secretome During Cancer Progression and Therapy.

Determinants and Functions of CAFs Secretome During Cancer Progression and Therapy.

Journal: Frontiers in cell and developmental biology
Published: October 24, 2020

Testing Cancer Immunotherapy in a Human Immune System Mouse Model: Correlating Treatment Responses to Human Chimerism, Therapeutic Variables and Immune Cell Phenotypes.

Testing Cancer Immunotherapy in a Human Immune System Mouse Model: Correlating Treatment Responses to Human Chimerism, Therapeutic Variables and Immune Cell Phenotypes.

Journal: Frontiers in immunology
Published: September 16, 2020
Showing 1-11 of 11

Last Updated: 09/26/2026